Baird Financial Group
MLAB icon

Baird Financial Group’s Mesa Laboratories MLAB Stock Holding History

Baird Financial Group’s Portfolio MLAB Stock Details MLAB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$231K Buy
+2,325
New +$234K ﹤0.01% 1824
2022
Q3 		– Sell
-1,220
Closed -$249K – 1785
2022
Q2 		$249K Sell
1,220
-25
-2% -$5.47K ﹤0.01% 1618
2022
Q1 		$317K Sell
1,245
-20
-2% -$5.43K ﹤0.01% 1597
2021
Q4 		$415K Sell
1,265
-3
-0.2% -$942 ﹤0.01% 1553
2021
Q3 		$383K Buy
+1,268
New +$360K ﹤0.01% 1581

Other funds holding MLAB

LPP
Long Path Partners Stamford, Connecticut $235M AUM 22.51% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $113B AUM 38.87% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
RIM
Ranger Investment Management Dallas, Texas $1.58B AUM 51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Diamond Hill Capital Management
Diamond Hill Capital Management Columbus, Ohio $12.5B AUM 7.49% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Baird Financial Group's MLAB Position: Q2 2026 in Review

Baird Financial Group opened a new position in Mesa Laboratories (MLAB) in Q2 2026: 2,325 shares worth $231K. The stake represents ﹤0.01% of the portfolio and ranks #1824 among its holdings. This is a return to the name: Baird Financial Group previously reported a position in MLAB as recently as Q2 2022.

Baird Financial Group first reported a position in MLAB in Q3 2021 and has held it in 5 quarters since. The position peaked at $415K in Q4 2021. 160 funds tracked by Wall St. Rank hold MLAB as of Q2 2026.

  • Baird Financial Group held 2,325 shares of Mesa Laboratories worth $231K as of Q2 2026.
  • Mesa Laboratories was a new Baird Financial Group position in Q2 2026.
  • Mesa Laboratories made up ﹤0.01% of Baird Financial Group's portfolio in Q2 2026, its #1824 holding.
  • Baird Financial Group first reported a position in Mesa Laboratories in Q3 2021 and has held it in 5 quarters since.
  • Baird Financial Group's Mesa Laboratories position peaked at $415K in Q4 2021.
  • 160 funds tracked by Wall St. Rank held Mesa Laboratories as of Q2 2026.

Based on Baird Financial Group's 13F filing for Q2 2026, filed 12 Aug 2026.